ProFound Therapeutics
PrivateLast Round
Corporate Funding
Jun 26, 2025
Total Funding Raised
$75M
Company Overview
ProFound Therapeutics is a biotechnology company that utilizes its proprietary ProFoundry™ Platform to systematically discover and validate novel proteins within the expanded human proteome for the development of first-in-class medicines.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProFound Therapeutics Comparables
Compare ProFound Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quotient Therapeutics | 88% | |
| Protai | 83% | |
| Vesalius Therapeutics | 82% |
ProFound Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jun 26, 2025 | ||||
| Series A | May 26, 2022 |
Key People
Founding team and executive leadership
ProFound Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Notley | Series A |
| Flagship Pioneering | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2025
$25M raised in corporate funding.
- Jun 26, 2025
Four-year deal to discover and develop novel therapeutics for cardiovascular disease.
Recent news
Latest coverage and updates
- receives_financingAug 27, 2026
ProFound received financing of $20M in investment on Aug 27th '26.
- receives_financingAug 27, 2026
ProFound received financing of $35M in investment on Aug 27th '26.
- partners_withAug 26, 2026
ProFound partnered with Bill & Melinda Gates Foundation on Aug 26th '26.
- hiresJul 15, 2026
Profoundtx hired Ainslie Little as Chief Operating Officer on Jul 15th '26.
ProFound Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ProFound Therapeutics's valuation, stock price, and market status.
Is ProFound Therapeutics a public or private company?
ProFound Therapeutics is a private company.
What is the current stock price of ProFound Therapeutics?
ProFound Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is ProFound Therapeutics worth (valuation)?
Valuation information for ProFound Therapeutics is not publicly available.
Can I buy ProFound Therapeutics stock?
ProFound Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ProFound Therapeutics's last funding round?
ProFound Therapeutics's most recent funding round was Corporate Funding on June 26, 2025.
Who are the main investors in ProFound Therapeutics?
Key investors in ProFound Therapeutics include Flagship Pioneering.
Will ProFound Therapeutics IPO soon?
No public IPO plans have been announced for ProFound Therapeutics.
How can I track ProFound Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ProFound Therapeutics's secondary market activity and sign up for updates.